An employee works in a warehouse with dry ice outside at the Pfizer Manufacturing plant in Puurs, Belgium, on Friday, Dec. 4, 2020. British officials on Wednesday authorized a COVID-19 vaccine for emergency use, greenlighting the world’s first shot against the virus that’s backed by rigorous science and taking a major step toward eventually ending the pandemic. (AP Photo/Olivier Matthys)

An employee works in a warehouse with dry ice outside at the Pfizer Manufacturing plant in Puurs, Belgium, on Friday, Dec. 4, 2020. British officials on Wednesday authorized a COVID-19 vaccine for emergency use, greenlighting the world’s first shot against the virus that’s backed by rigorous science and taking a major step toward eventually ending the pandemic. (AP Photo/Olivier Matthys)

UK defends vaccine decision amid criticism it moved too fast

LONDON — U.K. regulators went on the offensive Friday to beat back criticism that they rushed their authorization of a COVID-19 vaccine, saying they rigorously analyzed data on safety and effectiveness in the shortest time possible without compromising the thoroughness of their review.

The comments from the Medicines and Healthcare Products Regulatory Agency came as the Times newspaper reported that the agency’s chief executive, Dr. June Raine, planned to give a series of radio interviews so she could speak directly to people who may be concerned about getting vaccinated.

The MHRA reiterated earlier statements that the agency is conducting rolling reviews of COVID-19 vaccine candidates, allowing regulators to speed up the review process by looking at data as it becomes available. The agency gave emergency approval on Wednesday to a vaccine produced by U.S. drugmaker Pfizer and Germany-based BioNTech, making Britain the first Western country to authorize a vaccine against the coronavirus.

The ability to act more quickly “does not mean steps and the expected standards of safety, quality and effectiveness have been bypassed,” the MHRA said. “No vaccine would be authorized for supply in the U.K. unless the expected standards of safety, quality and efficacy are met.”

The media blitz comes amid concerns that criticism of the approval process could undermine public confidence in the Pfizer/BioNTech vaccine, leading some individuals to shun shots. Britain plans to begin vaccinating people within the next few days, starting with nursing home residents, caregivers and people over age 80.

Britain will initially receive 800,000 doses, enough to vaccinate 400,000 people, so the first shots will go to those who are most at risk of dying from COVID-19 and those who are most likely to spread the coronavirus.

America’s top infectious disease expert late Thursday apologized for suggesting that U.K. authorities had rushed their authorization of the vaccine.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, had told U.S. media outlets that U.K. regulators hadn’t acted “as carefully” as the Food and Drug Administration. He later clarified to the BBC that he had meant to say that U.S. authorities do things differently than their British counterparts, not better, but didn’t phrase his comments properly.

“I do have great faith in both the scientific community and the regulatory community at the U.K., and anyone who knows me and my relationship with that over literally decades, you know that’s the case,” Fauci told the BBC.

Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine, said the different approaches of various regulators may be one reason Britain was first to authorize the vaccine.

The FDA, for example, goes back to the raw data supplied by drugmakers and reanalyzes it to verify the findings. Virtually no other regulatory agency regularly does this, said Evans, who has worked with regulators in the U.K. and the European Union.

In addition, Britain decided to take advantage of EU rules that allow individual countries to allow the emergency use of new products inside their own borders in response to public health emergencies. The EU’s European Medicines Agency chose a more time-consuming authorization process that will allow the vaccine to be used in all 27 member nations.

While Britain left the European Union on Jan. 31, it remains bound by the bloc’s rules and regulations until the end of December under a transition agreement designed to ease the shock of Brexit.

Brexit helped the Medicines and Healthcare Products Regulatory Agency move faster because it is no longer involved in assessing products intended for the entire bloc as are regulators in the remaining EU countries, according to Evans. MHRA therefore had more resources to devote to the Pfizer/BioNTech vaccine and could respond more quickly when new data was submitted, he said.

“Consequently, the U.K. has almost undoubtedly had greater capacity to respond to a new application for authorization of a vaccine than any other country,” Evans said.

When the MHRA announced its decision on the Pfizer/BioNTech vaccine, chief executive Raine said people should be confident “no corners have been cut.” British experts reviewed more than 1,000 pages of information, including raw data, on safety, quality and effectiveness before deciding to give temporary authorization for use of the vaccine, she said.

But European officials reacted sourly to the U.K. decision.

The European Medicines Agency, which plans to make its own decision by Dec. 29, issued a statement saying its process was “more appropriate” than Britain’s.

Bavarian Governor Markus Soeder was more pointed, suggesting U.K. authorities had acted “without even sufficient basis.”

“This will reduce the readiness to get vaccinated rather than increase it, because people expect a safe immunization process,” he said.

In his latest comments, Fauci rejected the idea that the U.K. skipped vital steps.

The FDA has to move more slowly amid the high degree of skepticism about vaccines in the U.S., Fauci said. Because of this, U.S. regulators are reviewing all of the raw data from Pfizer and BioNTech “in a way that could not possibly have been done any more quickly,” he said.

It will take the FDA at least another week to complete its review, but the U.S. and Britain will ultimately end up in the same place, Fauci said.

“At the end of the day, it’s going to be safe, it’s going to be effective,” he said. “The people in the U.K. are going to receive it, and they’re going to do really well, and the people in the United States are going to receive it, and we’re going to do pretty well.”

___

Associated Press Writer Frank Jordans contributed.

___

Follow AP’s coverage at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/UnderstandingtheOutbreak.

Danica Kirka, The Associated Press

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

The Red Deer and District Community Foundation needs to sell more tickets to host a raffle that will benefit the Women and Girls Endowment Fund.
Red Deer & District Community Foundation grants $167K to local women’s initiatives

Initiatives supporting women, girls, Two-Spirit and gender-diverse individuals will receive a combined… Continue reading

City of Red Deer says its roundabouts have sharply reduced the number of injury collisions at a pair of busy intersections. Alberta Transportation wants to incorporate five roundabouts into plans to twin Highway 11 from Sylvan Lake to Rocky Mountain House. Photo by PAUL COWLEY/Advocate staff
Highway 11 roundabouts will increase safety based on Red Deer’s experience

Injury collisions sharply reduced at roundabout intersections in city

As of Friday, Alberta has under 10,000 active COVID-19 cases. (Image courtesy CDC)
One new COVID-19 death in Red Deer, Alberta under 10,000 active cases

Alberta reported an additional 643 COVID-19 cases Friday. The province now has… Continue reading

About 110 students from Red Deer Catholic Regional Schools participated in March for Life rally in Edmonton May 9. (File photo by Advocate staff)
Red Deer high school has COVID-19 case

St. Joseph High School in Red Deer confirmed a positive COVID-19 case… Continue reading

Lacombe High School logo.
Two more COVID-19 cases at Lacombe Composite High School

Lacombe Composite High School confirmed two more positive COVID-19 cases at the… Continue reading

Former Alberta Premier Rachel Notley shakes hands with Joel Ward, former Red Deer College President and CEO, as Notley announces that the college is on the path to grant degrees. Red Deer-South MLA Jason Stephan says university status is not a necessary condition for offering degrees. (File photo by Advocate staff)
Future of Red Deer University increasingly uncertain

MLA’s college update says RDC more like SAIT and NAIT than a university

Quebec Premier Francois Legault pauses as he speaks during a news conference on the COVID-19 pandemic, Thursday, Jan. 21, 2021 at the legislature in Quebec City. THE CANADIAN PRESS/Jacques Boissinot
Non-essential travel ban would violate Constitution but courts might allow it: expert

MONTREAL — Fear that Quebecers will catch a new variant of COVID-19… Continue reading

A Chinese flag is illuminated by sunshine in the Hall of Honour on Parliament Hill in Ottawa, Thursday, September 22, 2016. China is threatening retaliation against Canada after Prime Minister Justin Trudeau condemned a new security law giving Beijing more control over Hong Kong.. THE CANADIAN PRESS/Adrian Wyld
Diplomats contact Canadian held for over 2 years in China

BEIJING — Canadian officials have met online with former diplomat Michael Kovrig,… Continue reading

Marc Gold (centre) stands with senators André Pratte (left) and Peter Harder before being sworn in during a ceremony in the Senate on Parliament Hill, Thursday, Dec. 1, 2016 in Ottawa. THE CANADIAN PRESS/Justin Tang
Senator urges study of vexing barriers to using secret information in court cases

OTTAWA — A Senate committee should examine the hurdles that make it… Continue reading

A readers suggests using a hairdryer to open a tight jar lid. (Photo by The Associated Press)
The handy hairdryer hint

Dear Heloise: Whenever you have trouble opening a tight jar lid, set… Continue reading

Professional-quality tools don’t just last longer, they’re also more comfortable and better balanced. This drill and impact driver are perfectly balanced on the triggers, which is ideal. (Photo by Steve Maxwell)
In praise of professional-grade tools

When I was 10 years old, my dad began renovating our kitchen,… Continue reading

There are two confirmed COVID-19 cases at Red Deer College. Photo by Mamta Lulla/Advocate staff
Central Albertans were promised a university

Central Albertans were promised a university

FILE - Baseball Hall of Famer Hank Aaron sits for a portrait after receiving his COVID-19 vaccination at the Morehouse School of Medicine in Atlanta, in this Tuesday, Jan. 5, 2021, file photo. Hank Aaron, who endured racist threats with stoic dignity during his pursuit of Babe Ruth but went on to break the career home run record in the pre-steroids era, died early Friday, Jan. 22, 2021. He was 86. The Atlanta Braves said Aaron died peacefully in his sleep. No cause of death was given. (AP Photo/Ron Harris, File)
Hank Aaron, baseball’s one-time home run king, dies at 86

Hank Aaron, baseball’s one-time home run king, dies at 86

Miami Heat guard Duncan Robinson (55) passes the ball around Toronto Raptors guard Fred VanVleet (23) during the second half of an NBA basketball game Friday, Jan. 22, 2021, in Tampa, Fla. (AP Photo/Chris O'Meara)
Powell, Raptors regroup after blowing lead, beat Heat 101-81

Powell, Raptors regroup after blowing lead, beat Heat 101-81

Most Read